Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

NCT00950612 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: GSK's investigational vaccine 692342
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]